Diabetes as a Risk Factor in Atherosclerotic Cerebrovascular Disease


Diabetes mellitus (DM) has been described as an epidemic in progress. By 2050 its prevalence among adults in the United States is predicted to increase from 1 in 10 to 1 in 5. Additionally, in the adolescent population its incidence is on the rise. DM results from either the absolute deficiency of insulin (type 1 [T1DM]) or resistance to the action of insulin (type 2 [T2DM]). The diagnosis of T2DM is confirmed by two levels of fasting blood glucose (BG) higher than 126 mg/dL, by a 2-hour postprandial glucose of 200 mg/dL, and by the newer criteria of hemoglobin A 1c (A 1c ) 6.5% or higher. Two different abnormal criteria together can also make the diagnosis.

In stroke, as with other medical or surgical illnesses, high BG levels can occur without a history of DM. In the recent VISTA (Virtual International Stroke Trials Archive) analysis, 43% of stroke patients had admission hyperglycemia and 36% of those with elevated BG levels had no history of DM. This stress hyperglycemia is postulated to be either a protective mechanism during early stroke or an epiphenomenon that reflects the size and severity of a stroke. Conversely, numerous reports link hyperglycemia to poor stroke outcome in both DM and stress hyperglycemia.

The health burden of DM is related to its microvascular and macrovascular complications. Cardiovascular disease (CVD) is increased two- to threefold in persons with DM, independent of other risk factors, and stroke and coronary artery disease are major causes of death and morbidity, especially in those older than 65 years. In T1DM, CVD occurs 10 to 12 years after the initial diagnosis, but in T2DM it can occur as early as in the prediabetes stage. Although CVD is not as extensively studied in T1DM, its presence is often reported with nephropathy. In T2DM the presentation spectrum is wide.

Diabetes and Cerebrovascular Disease

Patients with DM have an increased risk of cerebral infarctions. Prospective epidemiologic data have found the incidence of ischemic stroke to be two- to threefold higher in DM, independent of other risk factors. Other risk factors include hypertension, hyperlipidemia, atrial fibrillation, and obesity and are found to be additive. Women with DM have a higher stroke risk than men.

Stroke Characteristics in Diabetes

In both T1DM and T2DM, the commonest stroke phenotype is an ischemic stroke. The lacunar (small cerebral artery) subtype is consistently the most common, especially multiple lacunar strokes. Hemorrhagic strokes are six times less common, and subarachnoid hemorrhages are rare in this population. Although carotid and basilar artery occlusion are a complication of the heavy burden of atherosclerotic disease in DM, large-vessel infarcts are less common. In some studies A 1c is independently related to the severity of carotid occlusion as well as to macroalbuminuria. The incidence of transient ischemic attacks (TIAs) in DM is variably reported, though the majority find a low incidence. It is postulated that irreversible and permanent damage caused by hyperglycemic neuronal changes lead to strokes rather than TIAs. Ischemic strokes in the setting of hyperglycemia are at high risk for hemorrhagic transformation, especially with reperfusion therapy. Various BG cutoffs ranging over 150 mg/dL are reported to increase this risk. DM patients also have a high incidence of stroke mortality, early recurrence, and physical disability, especially with brain stem or cerebellar infarction.

Pathophysiology of Stroke in Diabetes and Hyperglycemia

Although classified as a macrovascular complication, DM causes both extracranial atherosclerotic and cortical microangiopathic changes. Carotid occlusion is common, especially in the elderly. Endothelial damage from subclinical inflammation of the vessel wall (high levels of interleukin [IL]-6, tumor necrosis factor [TNF], and TNF-α), oxidative stress increasing reactive oxygen species, lipoprotein oxidation, altered platelet aggregation, inhibition of fibrinolysis, and hypercoagulability are some vasculature features in DM. Prolonged hyperglycemia increases permanent glycosylation end products. Vessel wall reactivity to nitric oxide (NO) and free radical production is altered. The brain microvasculature is also damaged by hyalinosis and altered glucose oxidation, all these factors contributing to arterial damage.

An acute ischemic event is usually mitigated by collateral circulation. The irreversibly damaged central area is surrounded by the hypoperfused penumbra within which viable cells switch to anaerobic respiration. Early hyperglycemia is favorable to this process, but if perfusion is not restored, continued production and accumulation of lactate leads to cell death, enlarging the infarct. Initial use of intravenous insulin is reported to have multifactorial benefits that include stress hormone reduction and vessel wall relaxation, which lower blood pressure (BP).

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here